Vita Coco Company, INC Form 4 insider transactions
NASDAQ
Vita Coco Company Director Kenneth Sadowsky sold 3,900 shares of common stock for a weighted average price of $47.115 per share under a Rule 10b5-1 trading plan.
NASDAQ
Vita Coco Company Director Ira Liran sold over 40,000 shares of common stock on November 17, 2025, through a pre-arranged 10b5-1 trading plan.
NASDAQ
Vita Coco's Chief Sales Officer, Charles van Es, exercised stock options and subsequently sold 20,000 shares of common stock under a pre-arranged trading plan.
NASDAQ
Jonathan Burth, Chief Operating Officer of Vita Coco Company, Inc., exercised stock options and subsequently sold a portion of his common stock holdings on November 17, 2025, pursuant to a Rule 10b5-1 trading plan.
NASDAQ
Michael Kirban, Executive Chairman of Vita Coco Company, Inc., sold 5,102 shares of common stock for $44 per share as part of a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Vita Coco Company Director John Zupo exercised stock options and subsequently sold 10,000 shares of common stock under a Rule 10b5-1 trading plan.
NASDAQ
Vita Coco Company Director Ira Liran sold 50,000 shares of common stock for approximately $2.07 million on November 5, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Vita Coco's Chief Marketing Officer, Jane Prior, exercised stock options and subsequently sold 10,000 shares of common stock under a Rule 10b5-1 plan.
NASDAQ
Ira Liran, a director of Vita Coco Company, Inc., sold 40,000 shares of common stock for approximately $1.82 million under a pre-arranged 10b5-1 trading plan.
NASDAQ
Vita Coco Company, Inc. Executive Chairman Michael Kirban reported the sale of 44,898 shares of common stock in late October 2025, executed under a Rule 10b5-1 trading plan.
NASDAQ
Vita Coco Company's Chief Operating Officer, Jonathan Burth, exercised stock options and subsequently sold a portion of the acquired common stock.
NASDAQ
Vita Coco Company CEO Martin Roper executed sales of common stock totaling 20,500 shares across direct and indirect holdings in late October 2025, as part of a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Vita Coco Company Director Kenneth Sadowsky sold 3,900 shares of common stock for approximately $38.915 per share under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Vita Coco Company CEO Martin Roper and affiliated trusts sold 7,894 shares of common stock for approximately $337,823 under a pre-arranged trading plan.
NASDAQ
Vita Coco Company CEO Martin Roper sold a total of 40,000 shares of common stock across direct and indirect holdings in early October 2025, pursuant to a pre-arranged 10b5-1 trading plan.
NASDAQ
Vita Coco Company CEO Martin Roper and related family trusts sold a total of 40,000 shares of common stock in early October 2025 under a pre-arranged 10b5-1 trading plan.
NASDAQ
Vita Coco Company CEO Martin Roper sold 40,000 shares of common stock across two days in late September 2025, pursuant to a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Jonathan Burth, Chief Operating Officer of Vita Coco Company, Inc., executed a pre-arranged transaction involving the exercise of stock options and subsequent sale of common stock.
NASDAQ
Vita Coco Company CEO Martin Roper and related trusts sold common stock totaling 21,600 shares in late September 2025 under a pre-arranged trading plan.
NASDAQ
Vita Coco Company CEO Martin Roper executed planned sales of common stock totaling 40,000 shares across direct and family trust holdings in late September 2025.
NASDAQ
Michael Kirban, Executive Chairman of Vita Coco Company, Inc., sold 20,000 shares of common stock for a weighted average price of $41.535 under a Rule 10b5-1 trading plan.
NASDAQ
Vita Coco Company CEO Martin Roper and related family trusts sold over 50,000 shares of common stock for approximately $2 million through a pre-arranged 10b5-1 trading plan.
NASDAQ
Vita Coco Company CEO Martin Roper and related family trusts sold 20,000 shares of common stock for approximately $40 per share under a pre-arranged trading plan.
NASDAQ
Vita Coco Company's Chief Sales Officer, Charles van Es, executed a Rule 10b5-1 trading plan, exercising stock options and selling common stock on September 17, 2025.
NASDAQ
Kenneth Sadowsky, a director at Vita Coco Company, Inc., sold 3,900 shares of common stock for approximately $40.03 per share pursuant to a pre-arranged trading plan.
NASDAQ
Vita Coco Company's Chief Marketing Officer, Jane Prior, exercised stock options and subsequently sold 10,000 shares of common stock for a significant profit.
NASDAQ
Vita Coco Company Director Ira Liran sold 50,000 shares of common stock for approximately $42.00 per share under a Rule 10b5-1 plan.
NASDAQ
Vita Coco Company's Executive Chairman, Michael Kirban, sold 30,000 shares of common stock for approximately $1.25 million under a pre-arranged trading plan.
NASDAQ
Vita Coco's Chief Operating Officer, Jonathan Burth, sold 16,827 shares of common stock for a weighted average price of $42.546 after exercising options.
NASDAQ
Verlinvest Beverages SA, a former 10% owner, sold 3 million shares of Vita Coco Company, Inc. common stock for $40.77 per share.